A whole family of peptides with completely unexpected activity has been discovered in spider venom. These peptides inhibit mammalian purinergic receptors with high affinity and selectivity. A peptide called purotoxin-6 (PT6) from the venom of the crab spider Thomisus onustus inhibits P2X3 receptors, an important pharmacological target in a number of pain syndromes and chronic cough. PT6 has a compact fold and exhibits a potent analgesic effect in animal models of osteoarthritis and trigeminal neuralgia. At the same time, unlike small-molecule P2X3 ligands that are being developed as drugs, purotoxin does not cause dysgeusia, i.e., distortion of the sense of taste. Research on purotoxins began at the Institute of Bioorganic Chemistry some 20 years ago under the supervision of Academician Eugene Grishin and was successfully continued by Alexander Vassilevski. The results, unique on a global scale, were published in Molecular Therapy.

Potassium channels are one of the major players in the transduction of the nerve impulse, and mutations in their genes lead to neurological and cardiovascular diseases. The most important feature of K+-channels is their highest selectivity for K+ over Na+ and other cations. In the new work, members of the Group of in silico Analysis of Membrane Proteins Structure and the Laboratory of Molecular Instruments for Neurobiology analyzed all known 3D-structures of membrane proteins. As a result, the key principle of K+-channel selectivity filter architecture was confirmed: within it, oxygen atoms of the protein backbone are arranged in a chain of square antiprisms, replicating exactly the solvation geometry of the potassium ion. Distortion of the filter, for example during inactivation, is detected by the algorithm developed by the authors, which can be used for structural classification.

Preeclampsia is a serious pregnancy complication characterized by hypertension and multi-organ involvement in pregnant women. This condition occurs in 2–8% of all pregnancies and remains one of the leading causes of maternal and perinatal mortality. Despite decades of research, the exact mechanisms of its development are not fully understood, and existing therapeutic strategies remain only partially effective. A new study published by a team of Russian scientists led by Evgeny Knyazev, Polina Vishnyakova, Olga Lazareva, and Alexander Tonevitsky provides an overview of modern cellular models of preeclampsia and their potential in the search for new diagnostic and therapeutic approaches.